Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to optimize and validate this MR-based GFR measurement in patients with a renal transplant, compared with the reference method, the Cr51- EDTA method: to select the most accurate combination of post-treatment of renal MR images and then evaluate its intra- and inter-rater reliability.


Clinical Trial Description

Cr51- EDTA method is considered the reference method for measurement of glomerular filtration rate (GFR). However, this method requires several hours and several blood and urinary samplings. Therefore, the ability to get access to this parameter with a simple, valid and reliable method would be a significant progress in clinical follow-up of patients with renal disease. Contrast-enhanced dynamic MRI is now able to give this access to functional parameters as GFR, rapidly and non invasively, becoming an alternative to Cr51-EDTA method. If the acquisition method has been optimized, some problems remain unsolved: is the movement correction worthwhile for the accuracy of the measurement ? Which model provides the most accurate results ? What is the best way to calculate the total GFR (addition of all the voxels or the product of a mean value by the cortical volume)? These questions can be answered only by a comparison with a reference method.

The reference method will be performed after standard hydration, with intravenous injection of 100 µCi of Cr51- EDTA and urinary and blood samplings every 30 minutes during 3h. Dynamic MRI will be performed with fast 3D T1-weighted gradient-echo sequences during 5 minutes after injection of a third of a clinical dose of gadolinium. Post-treatment of images will be done on an off-line program allowing movement correction, conversion of signal intensity into concentration and application of different models. 8 combinations of post-treatment will be tested and compared to the reference method. ;


Study Design

Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00614081
Study type Interventional
Source University Hospital, Bordeaux
Contact
Status Completed
Phase N/A
Start date January 2008
Completion date March 2013

See also
  Status Clinical Trial Phase
Completed NCT00189735 - A Study to Evaluate FK778 in Kidney Transplant Patients Phase 2
Recruiting NCT01150487 - Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients N/A
Completed NCT01656343 - Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
Completed NCT02625428 - IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? Phase 4
Not yet recruiting NCT00617474 - The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group Phase 1
Terminated NCT00365833 - CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients N/A
Withdrawn NCT01496729 - Transversus Abdominis Plane (TAP) Block After Kidney Transplantation N/A
Completed NCT00861536 - Comparison of ATG to Thymoglobuline in Renal Transplantation Phase 4
Completed NCT03977051 - Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Terminated NCT00568477 - Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation Phase 2
Completed NCT04874740 - Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
Available NCT01236287 - Special Access for the Use of Voclosporin for Kidney Transplantation